|
|
|
- Hubert Barrett
- 10 years ago
- Views:
Transcription
1 Roberti G, Mantelli F, Macchi I, Massaro-Giordano M, Centofanti M. Nerve Growth Factor Modulation of Retinal Ganglion Cell Physiology. J Cell Physiol Feb 6. doi: /jcp [Epub ahead of print] PubMed PMID: Cupo G, Scarinci F, Ripandelli G, Sampalmieri M, Centofanti M, Giusti C, Lazzeri S. A novel index for predicting macular thickening after cataract surgery. Eur Rev Med Pharmacol Sci Dec;17(23): PubMed PMID: Parravano M, Oddone F, Boccassini B, Centofanti M, Tanga L, Cacciamani A, Borboni P, Varano M. Functional retinal impairment in type 1 diabetic patients without any signs of retinopathy. Ophthalmic Res. 2013;50(2): doi: / Epub 2013 Jul 3. PubMed PMID: Fogagnolo P, Orzalesi N, Centofanti M, Oddone F, Manni G, Rossetti L. Shortand long-term phasing of intraocular pressure in stable and progressive glaucoma. Ophthalmologica. 2013;230(2): doi: / Epub 2013 Jun 21. PubMed PMID: Ottobelli L, Manni GL, Centofanti M, Iester M, Allevena F, Rossetti L. Citicoline oral solution in glaucoma: is there a role in slowing disease progression? Ophthalmologica. 2013;229(4): doi: / Epub 2013 Apr 24. PubMed PMID: Bagnis, A., Izzotti, A., Centofanti, M., Saccà, S.C. Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma (2012) Experimental Eye Research, 103, pp Saccà, S.C., Centofanti, M., Izzotti, A. New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. (2012) Investigative ophthalmology & visual science, 53 (7), pp Izzotti, A., Centofanti, M., Saccà, S.C. Molecular diagnostics of ocular diseases: The application of antibody microarray (2012) Expert Review of Molecular Diagnostics, 12 (6), pp Fogagnolo, P., Sangermani, C., Oddone, F., Frezzotti, P., Iester, M., Figus, M., Ferreras, A., Romano, S., Gandolfi, S., Centofanti, M., Rossetti, L., Orzalesi, N.Authors' response (2011) British Journal of Ophthalmology, 95 (11), pp Iester, M., Oddone, F., Prato, M., Centofanti, M., Fogagnolo, P., Rossetti, L., Vaccarezza, V., Manni, G., Ferreras, A. Linear discriminant functions to improve the glaucoma probability score analysis to detect glaucomatous optic nerve heads: A multicenter study (2011) Journal of Glaucoma,. Article in Press. Oddone, F., Centofanti, M., Tanga, L., Parravano, M., Michelessi, M., Schiavone, M., Villani, C.M., Fogagnolo, P., Manni, G. Influence of disc size on optic nerve head versus retinal nerve fiber layer assessment for diagnosing glaucoma (2011) Ophthalmology, 118 (7), pp Tanga, L., Centofanti, M., Oddone, F., Parravano, M., Parisi, V., Ziccardi, L., Kroegler, B., Perricone, R., Manni, G. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine (2011) Graefe's Archive for Clinical and Experimental Ophthalmology, 249 (5), pp
2 Tranchina, L., Centofanti, M., Oddone, F., Tanga, L., Roberti, G., Liberatoscioli, L., Cortese, C., Manni, G. Levels of plasma homocysteine in pseudoexfoliation glaucoma (2011) Graefe's Archive for Clinical and Experimental Ophthalmology, 249 (3), pp Fogagnolo, P., Sangermani, C., Oddone, F., Frezzotti, P., Iester, M., Figus, M., Ferreras, A., Romano, S., Gandolfi, S., Centofanti, M., Rossetti, L., Orzalesi, N. Long-term perimetric fluctuation in patients with different stages of glaucoma (2011) British Journal of Ophthalmology, 95 (2), pp Centofanti, M., Oddone, F., Gandolfi, S., Hommer, A., Boehm, A., Tanga, L., Sangermani, C., Sportelli, V., Haustein, M., Manni, G., Rossetti, L. Comparison of travoprost and bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination (2010) American Journal of Ophthalmology, 150 (4), pp Cited 9 times. Fogagnolo, P., Tanga, L., Rossetti, L., Oddone, F., Manni, G., Orzalesi, N., Centofanti, M. Mild learning effect of short-wavelength automated perimetry using SITA program (2010) Journal of Glaucoma, 19 (5), pp Cited 1 time. Centofanti, M., Oddone, F., Vetrugno, M., Manni, G., Fogagnolo, P., Tanga, L., Ferreri, P., Rossetti, L. Author's reply (2010) European Journal of Ophthalmology, 20 (1), pp Centofanti, M., Oddone, F., Vetrugno, M., Manni, G., Fogagnolo, P., Tanga, L., Ferreri, P., Rossetti, L. Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: A multicenter, randomized, investigator-masked, clinical study (2009) European Journal of Ophthalmology, 19 (1), pp Cited 13 times. Lambiase, A., Aloe, L., Centofanti, M., Parisi, V., Mantelli, F., Colafrancesco, V., Manni, G.L., Bucci, M.G., Bonini, S., Levi-Montalcini, R. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma (2009) Proceedings of the National Academy of Sciences of the United States of America, 106 (32), pp Oddone, F., Centofanti, M., Iester, M., Rossetti, L., Fogagnolo, P., Michelessi, M., Capris, E., Manni, G. Sector-Based Analysis with the Heidelberg Retinal Tomograph 3 Across Disc Sizes and Glaucoma Stages. A Multicenter Study (2009) Ophthalmology, 116 (6), pp e3. Cited 5 times. Parravano, M., Oddone, F., Mineo, D., Centofanti, M., Borboni, P., Lauro, R., Tanga, L., Manni, G. The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes (2008) British Journal of Ophthalmology, 92 (12), pp Cited 11 times. Manni, G., Oddone, F., Parisi, V., Tosto, A., Centofanti, M. Intraocular pressure and central corneal thickness (2008) Progress in Brain Research, 173, pp Cited 4 times.
3 Parisi, V., Coppola, G., Centofanti, M., Oddone, F., Maria Angrisani, A., Ziccardi, L., Ricci, B., Quaranta, L., Manni, G. Evidence of the neuroprotective role of citicoline in glaucoma patients (2008) Progress in Brain Research, 173, pp Centofanti, M., Fogagnolo, P., Oddone, F., Orzalesi, N., Vetrugno, M., Manni, G., Rossetti, L. Learning effect of humphrey matrix frequency doubling technology perimetry in patients with ocular hypertension (2008) Journal of Glaucoma, 17 (6), pp Oddone, F., Centofanti, M., Rossetti, L., Iester, M., Fogagnolo, P., Capris, E., Manni, G. Exploring the Heidelberg Retinal Tomograph 3 Diagnostic Accuracy across Disc Sizes and Glaucoma Stages. A Multicenter Study (2008) Ophthalmology, 115 (8), pp e3. Rossetti, L., Karabatsas, C.H., Topouzis, F., Vetrugno, M., Centofanti, M., Boehm, A., Viswanathan, A., Vorwerk, C., Goldblum, D. Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on Circadian Intraocular Pressure (2007) Ophthalmology, 114 (12), pp e1. Fogagnolo, P., McNaught, A., Centofanti, M., Rossetti, L., Orzalesi, N. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes (2007) Investigative Ophthalmology and Visual Science, 48 (10), pp Centofanti, M., Oddone, F., Chimenti, S., Tanga, L., Citarella, L., Manni, G. Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy (2006) American Journal of Ophthalmology, 142 (6), pp Rossetti, L., Fogagnolo, P., Miglior, S., Centofanti, M., Vetrugno, M., Orzalesi, N. Learning effect of short-wavelength automated perimetry in patients with ocular hypertension (2006) Journal of Glaucoma, 15 (5), pp Parisi, V., Miglior, S., Manni, G., Centofanti, M., Bucci, M.G. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma (2006) Ophthalmology, 113 (2), pp Centofanti, M., Oddone, F., Parravano, M., Gualdi, L., Bucci, M.G., Manni, G. Corneal birefringence changes after laser assisted in situ keratomileusis and their influence on retinal nerve fibre layer thickness measurement by means of scanning laser polarimetry (2005) British Journal of Ophthalmology, 89 (6), pp Bucci, M.G., Centofanti, M., Oddone, F., Parravano, M., Balacco Gabrieli, C., Pecori-Giraldi, J., Librando, A., Paone, E., Bores, L.D. Pilot study to evaluate the efficacy and safety of pneumatic trabeculoplasty in glaucoma and ocular hypertension (2005) European Journal of Ophthalmology, 15 (3), pp Manni, G., Centofanti, M., Oddone, F., Parravano, M., Bucci, M.G. Interleukin-1β tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers (2005) American Journal of Ophthalmology, 139 (1), pp
4 Manni, G., Centofanti, M., Parravano, M., Oddone, F., Bucci, M.G. A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients (2004) Graefe's Archive for Clinical and Experimental Ophthalmology, 242 (9), Manni, G., Centofanti, M., Sacchetti, M., Oddone, F., Bonini, S., Parravano, M., Bucci, M.G. Demographic and Clinical Factors Associated with Development of Brimonidine Tartrate 0.2%-Induced Ocular Allergy (2004) Journal of Glaucoma, 13 (2), pp Marcozzi, G., Liberati, V., Madia, F., Centofanti, M., De Feo, G. Age- and gender-related differences in human lacrimal fluid peroxidase activity (2003) Ophthalmologica, 217 (4), pp Manni, G., Centofanti, M., Gregori, D., Oddone, F., Scipioni, M., Migliardj, R., Bucci, M.G. The pulsatile ocular blood flow behaviour in open angle glaucoma patients after replacing timolol therapy with timolol and dorzolamide fixed combination: Preliminary study (2002) Acta Ophthalmologica Scandinavica, Supplement, 80 (236), pp Centofanti, M., Migliardi, R., Bonini, S., Manni, G., Bucci, M.G., Pesavento, C.B., Amin, C.S., Harris, A. Pulsatile ocular blood flow during pregnancy (2002) European Journal of Ophthalmology, 12 (4), pp Parisi, V., Manni, G., Centofanti, M., Gandolfi, S.A., Olzi, D., Bucci, M.G. Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients (2001) Ophthalmology, 108 (5), pp Centofanti, M., Zarfati, D., Manni, G.L., Bonini, S., Migliardi, R., Oddone, F., Harris, A., Bucci, M.G. The influence of oestrogen on the pulsatile ocular blood flow (2000) Acta Ophthalmologica Scandinavica, Supplement, 78 (232), pp Centofanti, M., Bonini, S., Manni, G., Guinetti-Neuschüler, C., Bucci, M.G., Harris, A. Do sex and hormonal status influence choroidal circulation? (2000) British Journal of Ophthalmology, 84 (7), pp Centofanti, M., Manni, G., Gregori, D., Cocco, F., Lorenzano, D., Bucci, M.G. Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma (2000) Graefe's Archive for Clinical and Experimental Ophthalmology, 238 (4), pp Centofanti, M., Manni, G.L., Gregori, D., Parisi, V., Cocco, F., Bucci, M.G. Brimonidine 0.2% behaviour on intraocular pressure in Timolol-uncontrolled glaucomatous patients (1999) Acta Ophthalmologica Scandinavica, Supplement, 77 (229), p. 52. Parisi, V., Manni, G., Gandolfi, S.A., Centofanti, M., Colacino, G., Bucci, M.G. Visual function correlates with nerve fiber layer thickness in eyes affected by ocular hypertension (1999) Investigative Ophthalmology and Visual Science, 40 (8), pp Parisi, V., Manni, G.L., Sgrulletta, R., Colacino, G., Centofanti, M., Bucci, M.G. Delayed postretinal neural conduction in glaucoma patients: Correlations between electrophysiological and computerized static perimetry parameters (1997) Acta Ophthalmologica Scandinavica, Supplement, 75 (224), pp
5 Manni, G.L., Centofanti, M., Napoli, D., Parisi, V., Bucci, M.G. Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: A comparative study with oral acetazolamide (1997) Acta Ophthalmologica Scandinavica, Supplement, 75 (224), pp Lambiase, A., Centofanti, M., Micera, A., Manni, G.L., Mattei, E., De Gregorio, A., De Feo, G., Bucci, M.G., Aloe, L. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension (1997) Graefe's Archive for Clinical and Experimental Ophthalmology, 235 (12), pp Centofanti, M., Manni, G.L., Napoli, D., Bucci, M.G. Comparative effects on intraocular pressure between systemic and topical carbonic anhydrase inhibitors: A clinical masked, cross-over study (1997) Pharmacological Research, 35 (5), pp Cited 15 times. Manni, G., Lambiase, A., Centofanti, M., Mattei, E., De Gregorio, A., Aloe, L., De Feo, G. Histopathological evaluation of retinal damage during intraocular hypertension in rabbit: Involvement of ganglion cells and Nerve Fiber Layer (1996) Graefe's Archive for Clinical and Experimental Ophthalmology, 234 (SUPPL. 1), pp. S209-S213. Centofanti, M., Schiavone, M., Lambiase, A., Taffara, M., Giuffrida, S., Bonini, S. Efficacy of Mipragoside ophthalmic gel in vernal keratoconjunctivitis (1996) Eye, 10 (4), pp Magrini, L., Bonini, S., Centofanti, M., Schiavone, M., Bonini, S. Tear tryptase levels and allergic conjunctivitis (1996) Allergy: European Journal of Allergy and Clinical Immunology, 51 (8), pp Bonini, S., Lambiase, A., Schiavone, M., Centofanti, M., Palma, L.A., Bonini, S. Estrogen and progesterone receptors in vernal keratoconjunctivitis (1995) Ophthalmology, 102 (9), pp Bonini, S., Centofanti, M., Schiavone, M., Lambiase, A., Bonini, S. The pattern of the ocular late phase reaction induced by allergen challenge in hay fever conjunctivitis (1994) Ocular Immunology and Inflammation, 2 (4), pp Schiavone, M., Librando, G., Centofanti, M., Arena, D., Sgrulletta, R. Comparative effects of epinephrine-metipranolol and epinephrine-dapiprazole on intraocular pressure and pupil diameter (1994) Annali di Ottalmologia e Clinica Oculistica, 120 (6), pp Bonini, S., Barney, N.P., Schiavone, M., Centofanti, M., Berruto, A., Bonini, S., Allansmith, M.R. Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis (1992) Eye, 6 (6), pp Bonini, S., Bonini, S., Schiavone, M., Centofanti, M., Allansmith, M.R., Bucci, M.G. Conjunctival hyperresponsiveness to ocular histamaine challenge in patients with vernal conjunctivitis (1992) Journal of Allergy and Clinical Immunology, 89 (1 I), pp. 103-
6 Schiavone, M., Di Palma, G., Bonini, S., Berruto, A., Cantera, E., Centofanti, M., Bucci, M.G. Neutrophil and eosinophil inhibition in allergic tardive ocular reactions [INIBIZIONE NEUTROFILA ED EOSINOFILA NELLE REAZIONI ALLERGICHE TARDIVE OCULARI] (1990) Annali di Ottalmologia e Clinica Oculistica, 116 (5), pp Berruto, A., Schiavone, M., Bonini, S., Manni, G.L., Centofanti, M., Bucci, M.G. Allergic conjunctivitis: Effect of naproxen after specific conjunctival stimulation [CONGIUNTIVITI ALLERGICHE: EFFETTO DEL NAPROSSENE DOPO STIMOLAZIONE CONGIUNTIVALE SPECIFICA] (1990) Annali di Ottalmologia e Clinica Oculistica, 116 (5), pp Berruto, A., Centofanti, M., Bonini, S., Manni, G.L., Schiavone, M., Bucci, M.G. Effectiveness of disodium cromoglycate in the immediate and tardive phase of the allergic ocular reaction [EFFICACIA DEL DISODIOCROMOGLICATO SULLE FASI IMMEDIATA E TARDIVE DELLA REAZIONE ALLERGICA OCULARE] (1990) Annali di Ottalmologia e Clinica Oculistica, 116 (5), pp
Dr. Francesco Oddone, MD, PhD. Glaucoma and Cataract Specialist. Capitoli di libro
Dr. Francesco Oddone, MD, PhD Glaucoma and Cataract Specialist Capitoli di libro 1. ODDONE F. HRT: Pros and cons for diagnosis and progression. In: European Glaucoma Society Book on Imaging for Glaucoma.
Optic Nerve Imaging. Management of Glaucoma
Optic Nerve Imaging in the Diagnosis and Management of Glaucoma Scott D. Smith, MD, MPH Associate Professor of Clinical Ophthalmology Director, Glaucoma Service Columbia University, New York, NY Glaucoma
11/11/2015. Glaucoma: Diagnosis and Treatment. Financial disclosures. Glaucoma: the problem. Joshua J. Ney, M.D. No disclosures to report
Glaucoma: Diagnosis and Treatment Joshua J. Ney, M.D. No disclosures to report Financial disclosures Glaucoma: the problem Glaucoma is second most common cause of blindness worldwide 7 million people are
Case Report Laser Vision Correction on Patients with Sick Optic Nerve: A Case Report
Case Reports in Ophthalmological Medicine Volume 2011, Article ID 796463, 4 pages doi:10.1155/2011/796463 Case Report Laser Vision Correction on Patients with Sick Optic Nerve: A Case Report Ming Chen
Dropout Rates for Intent-to-Treat and Per Protocol Analyses WILLIAM C. STEWART, MD, ANGI L. JACKSON, AND JESSICA N. JENKINS
Dropout Rates for Intent-to-Treat and Per Protocol Analyses WILLIAM C. STEWART, MD, ANGI L. JACKSON, AND JESSICA N. JENKINS PURPOSE: To describe dropout rates for the intent-totreat and per protocol analyses
NC DIVISION OF SERVICES FOR THE BLIND POLICIES AND PROCEDURES VOCATIONAL REHABILITATION
NC DIVISION OF SERVICES FOR THE BLIND POLICIES AND PROCEDURES VOCATIONAL REHABILITATION Section: E Revision History Revised 01/97; 05/03; 02/08; 04/08; 03/09; 05/09; 12/09; 01/11; 12/14 An individual is
Treatments for Open-Angle Glaucoma. A Review of the Research for Adults
Treatments for Open-Angle Glaucoma A Review of the Research for Adults Is This Information Right for Me? Yes, this information is for you if: Your eye doctor has said that you have open-angle glaucoma,
EXPANDING YOUR HORIZONS
Glaucoma Therapy EXPANDING YOUR HORIZONS Learn how to control glaucoma with SLT therapy. SLTPATIENT EDUCATION PROGRAM Glaucoma Glaucoma is a degenerative disease that if left untreated can cause permanent
Glaucoma. Quick reference guide. Issue date: April 2009. Diagnosis and management of chronic open angle glaucoma and ocular hypertension
Issue date: April 2009 Glaucoma Diagnosis and management of chronic open angle glaucoma and ocular hypertension Developed by the National Collaborating Centre for Acute Care About this booklet This is
Glaucoma. OET: Reading Part A. Reading Sub-test. Complete the following summary using the information in the four texts provided.
Glaucoma Reading Sub-test TIME LIMIT: 15 MINUTES Complete the following summary using the information in the four texts provided. You do not need to read each text from beginning to end to complete the
Eye Diseases. 1995-2014, The Patient Education Institute, Inc. www.x-plain.com otf30101 Last reviewed: 05/21/2014 1
Eye Diseases Introduction Some eye problems are minor and fleeting. But some lead to a permanent loss of vision. There are many diseases that can affect the eyes. The symptoms of eye diseases vary widely,
Robert T. Chang, M.D.
Robert T. Chang, M.D. HIGHER EDUCATION 2009 present Assistant Professor of Ophthalmology Palo Alto, CA Department of Ophthalmology, Glaucoma Stanford University School of Medicine Oct. 2008 Board Certified,
ACTIVITY DISCLAIMER. Glaucoma DISCLOSURE. Learning Objectives. Audience Engagement System Step 1 Step 2 Step 3. Jeffrey SooHoo, MD. Jeffrey SooHoo, MD
Glaucoma Jeffrey SooHoo, MD ACTIVITY DISCLAIMER The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. This material is not intended
IMAGE ASSISTANT: OPHTHALMOLOGY
IMAGE ASSISTANT: OPHTHALMOLOGY Summary: The Image Assistant has been developed to provide medical doctors with a software tool to search, display, edit and use medical illustrations of their own specialty,
GLAUCOMA. American Academy of Ophthalmology
GLAUCOMA American Academy of Ophthalmology What is glaucoma? Glaucoma is a disease of the optic nerve, which is the part of the eye that carries the images we see to the brain. The optic nerve is made
Principles of Ophthalmic Nursing Unit Outline
Principles of Ophthalmic Nursing Unit Outline Continuing Professional Education (CPE) Course: Application for credit worthiness in progress Prerequisites: Nil Incompatible Units: Nil Co ordinator: Amanda
Visual Disorders in Middle-Age and Elderly Patients with Diabetic Retinopathy
Medical Care for the Elderly Visual Disorders in Middle-Age and Elderly Patients with Diabetic Retinopathy JMAJ 46(1): 27 32, 2003 Shigehiko KITANO Professor, Department of Ophthalmology, Diabetes Center,
Glaucoma. The sneak thief of sight
Glaucoma The sneak thief of sight Glaucoma, a leading cause of blindness, affects more than two million Americans and is responsible for fifteen percent of world blindness. It is a family of ocular diseases
Measure of Confidence. Glaucoma Module Premium Edition
Measure of Confidence Glaucoma Module Premium Edition The Changing Face of Glaucoma Practice Literature 1 Leske et al., Arch Ophthalmol 1997; 115:1051-1057 2 Doughty et al., Surv Ophthalmol 2000; 44:367-408
CURRICULUM VITAE PATRICK JOHN RIEDEL, M.D.
CURRICULUM VITAE PATRICK JOHN RIEDEL, M.D. WORK ADDRESS: Minnesota Eye Consultants, PA 9801 Dupont Ave S, Suite 200 Bloomington, MN 55431 TELEPHONE: 952-888-5800 MEDICAL LICENSURE: 7/12/03 - Present State
Curriculum for the Glaucoma EBO-EGS Subspecialty exam/diploma (Glaucoma-medical)
Curriculum for the Glaucoma EBO-EGS Subspecialty exam/diploma (Glaucoma-medical) This curriculum will concentrate on: 1) General requirements for the candidate 2) Requirements for the institution and the
EFFECT OF MYOPIC LASIK ON RETINAL NERVE FIBER LAYER THICKNESS- IS IT SAFE OR UNSAFE?
24. Glaucoma: Imaging EFFECT OF MYOPIC LASIK ON RETINAL NERVE FIBER LAYER THICKNESS- IS IT SAFE OR UNSAFE? Chief Author: Dr. Amit porwal 1 Co-Authors: Dr. Kavita Porwal 2, Dr. Puja Rai 1 1. Choithram Netralaya,
Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology
Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology The chart below lists the measures (and specialty exclusions) that eligible providers must demonstrate
NEW YORK UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF OPHTHALMOLOGY SUPERVISION OF RESIDENTS POLICY
NEW YORK UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF OPHTHALMOLOGY SUPERVISION OF RESIDENTS POLICY Applies to: All Ophthalmology Residents, including those in ACGME- and non-acgme-accredited specialty
Re: LUMIGAN 0.03% (bimatoprost ophthalmic solution 0.03%) and LUMIGAN 0.01% (bimatoprost ophthalmic solution 0.01%)
Allergan Ltd, 1st Floor, Marlow International, Parkway, Marlow, Bucks SL7 1YL Tel: (01628) 494444 Facsimile: (01628) 494449 Ref No: UK15-000677 Mandeep Allingham NW Surrey CCG February 18, 2015 Dear Ms
Michael R. Willman, D.O.
Michael R. Willman, D.O. CURRENT AFFILIATION Partner at Waynesborough Ophthalmology in Goldsboro, North Carolina. Comprehensive ophthalmologist with a concentration in glaucoma, fellowship trained in medical
An Informational Guide to CENTRAL RETINAL VEIN OCCLUSION
Science of CRVO www.scienceofcrvo.org An Informational Guide to CENTRAL RETINAL VEIN OCCLUSION This brochure will guide you in understanding CRVO and the treatment options available to prevent vision loss.
Principles of Diagnosis MEDICAL DECISION-MAKING IN OPTOMETRIC PRACTICE. Medical Decision-Making. Medical Decision-Making.
MEDICAL DECISION-MAKING IN OPTOMETRIC PRACTICE Craig Thomas, O.D. 3900 West Wheatland Road Dallas, Texas 75237 972-780-7199 [email protected] Principles of Diagnosis The study of the art and science of
SECONDARY GLAUCOMA: Pseudoexfoliation (PXF), Pigmentary Dispersion Syndrome (PDS), Neovascular (NV), Uveitic
SECONDARY GLAUCOMA: Pseudoexfoliation (PXF), Pigmentary Dispersion Syndrome (PDS), Neovascular (NV), Uveitic Many roads can lead to glaucoma. With the exception of primary open-angle glaucoma (POAG) and
PATIENT CONSENT FOR LASER IN-SITU KERATOMILEUSIS (LASIK)
INTRODUCTION: You have been diagnosed with myopia (nearsightedness) or hyperopia (farsightedness) with or without astigmatism, or astigmatism alone. Myopia is a result of light entering the eye and focusing
FDA approves Lucentis (ranibizumab injection) for treatment of diabetic macular edema
Media Release Basel, 13 August 2012 FDA approves Lucentis (ranibizumab injection) for treatment of diabetic macular edema First major treatment advance in more than 25 years for sight-threatening condition
Elenco dei periodici elettronici in Ovid Full text
Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders
ACTVE INTERVENTIONAL CLINICAL TRIALS - 03/01/2015. Principal Investigator Study Title and Sponsor Study Description
Cornea and External Disease Service Li, Jennifer A Prospective, Multicenter Post-Approval Study (PAS) of VisionCare s Implantable Miniature Telescope (by Dr. Isaac Lipshitz) in Patients with Bilateral
How To Understand The Current Of An Optic Nerve Fiber Layer
A Practical Guide for Journal Interpretation of Current of Optical Glaucoma Coherence Practice, Tomography January-April Retinal 2009;3(1):9-13 Nerve Fiber Layer Measurement A Practical Guide for Interpretation
New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel
New Frontiers in Glaucoma Management Rome, 7 February 2014 Donna Camilla Savelli Hotel FACULTY Marco Centofanti University of Rome Tor Vergata Head of Glaucoma Research Line IRCCS - Fondazione Bietti Rome
BSM Connection elearning Course
BSM Connection elearning Course Scope of the Eye Care Practice 2008, BSM Consulting All Rights Reserved. Table of Contents OVERVIEW...1 THREE O S IN EYE CARE...1 ROUTINE VS. MEDICAL EXAMS...2 CONTACT LENSES/GLASSES...2
Preparing for ICD-10 Advance Preparation for Implementation Charles Brownlow, OD [email protected]
Preparing for ICD-10 Advance Preparation for Implementation Charles Brownlow, OD [email protected] International Classification of Diseases (ICD-9, ICD-10) Both include codes for all medical conditions,
Some of the ophthalmic surgeries performed at the DMV Center.
Some of the ophthalmic surgeries performed at the DMV Center. This document presents some types of the surgeries performed by the ophthalmology service at the DMV veterinary center as well as the equipment
The Normative Database for the RTVue. Software version 4.0. Michael J. Sinai, PhD
The Normative Database for the RTVue Software version 4.0 Michael J. Sinai, PhD Glaucoma is a multi-factorial optic neuropathy with characteristic structural changes and subsequent functional impairment.
Selective Laser Trabeculoplasty (SLT)
James Paget University Hospitals NHS Foundation Trust Ophthalmology Department Selective Laser Trabeculoplasty (SLT) Patient Information What is Glaucoma? Glaucoma is a slowly progressive disease which
Background & objectives
Indian J Med Res 138, October 2013, pp 531-535 Evaluation of the effectiveness of diagnostic & management decision by teleophthalmology using indigenous equipment in comparison with in-clinic assessment
Guide to Eye Surgery and Eye-related Claims
If you or a loved one have suffered because of a negligent error during eye treatment or surgery, you may be worried about how you will manage in the future, particularly if your eyesight has been made
[email protected] Modena March 3, 2009
A novel molecular marker of severe asthma Sergio Bonini Professor of Medicine, Second University of Naples INMM-CNR, ARTOV, Rome [email protected] i@ il Modena March 3, 2009 Circulating nerve growth
The Eye Care Center of New Jersey 108 Broughton Avenue Bloomfield, NJ 07003
The Eye Care Center of New Jersey 108 Broughton Avenue Bloomfield, NJ 07003 Dear Patient, Welcome to The Eye Care Center of New Jersey! It means a great deal to us that you have chosen us to serve as your
Trends in Ophthalmology a Market Perspective. Matthias Karl, Michael Kempe
Trends in Ophthalmology a Market Perspective Matthias Karl, Michael Kempe 30.04.2013 Agenda 1 2 3 4 Role of Optical Technologies in Ophthalmology Demands of the Market - Trends in the Application Implications
IR Conference Call on EYLEA (aflibercept) Injection in Diabetic Macular Edema. September 28, 2013
IR Conference Call on EYLEA (aflibercept) Injection in Diabetic Macular Edema September 28, 2013 Safe Harbor Statement This presentation includes forward-looking statements that involve risks and uncertainties
Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension
Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension NICE guideline Draft for consultation, September 2008 If you wish to comment on this version of the guideline,
Get Your Eyes Examined
1 Vision Changes You may notice vision changes with aging. Many changes are common and can often be corrected. As you get older, you are at higher risk of age-related eye diseases and conditions. Get Your
LIVING WITH GLAUCOMA Volume 29, Number 1
LIVING WITH GLAUCOMA Volume 29, Number 1 Fall 2014 DECODING THE VISUAL FIELD AND OTHER GLAUCOMA CONCERNS Dr. Daniel Laroche opened his address on September 20, 2014 at the Glaucoma Support group by complimenting
Visual Field Testing
CLINICAL GUIDELINE Visual Field Testing Important notes on these guidelines: This document is intended for optometrists in clinical practice for their use in assessing when a visual field test is required
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
Getting Ready for ICD-10. Dianna Hoskins, OCS Cincinnati Eye Institute
Dianna Hoskins, OCS Cincinnati Eye Institute Chart Documentation: Will your documentation stand up to ICD-10? Do you always mark which eye, severity or status of the disease (chronic or acute), site, etiology
Measure #12 (NQF 0086): Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation National Quality Strategy Domain: Effective Clinical Care
Measure #12 (NQF 0086): Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Understanding Visual Fields, Part III; Which Field Should Be Performed?
Journal of Ophthalmic Medical Technology Volume 3, Number 1 February 2007 www.jomtonline.com Understanding Visual Fields, Part III; Which Field Should Be Performed? Michael N. Wiggins, MD and Inci Dersu,
THE EYE INSTITUTE. Dear Patient:
THE EYE INSTITUTE Eye Associates of Wayne P.A. 968 Hamburg Turnpike Wayne, NJ 07470 p. 973-696-0300 f. 973-696-0464 Eye Institute North, LLC 5677 Berkshire Valley Rd. Oak Ridge, NJ 07438 p. 973-208-0600
Glaucoma: Treatment Options. National Glaucoma Research
Glaucoma: Treatment Options National Glaucoma Research Glaucoma: Treatment Options The nonprofit BrightFocus Foundation is an international leader in supporting innovative research to find cures for Alzheimer
istent Trabecular Micro-Bypass Stent Reimbursement Guide
istent Trabecular Micro-Bypass Stent Reimbursement Guide Table of Contents Overview Coding 3 4 Coding Overview Procedure Coding Device Coding Additional Coding Information Coverage Payment 10 11 Payment
9/16/2014. Anti-Immunoglobulin E (IgE) Omalizumab (Xolair ) Dosing Guidance
Disclosure Statement of Financial Interest New Therapies for Asthma Including Omalizumab and Anti-Cytokine Therapies Marsha Dangler, PharmD, BCACP Clinical Pharmacy Specialist James H. Quillen VA Medical
Pharmacological management of night vision disturbances after refractive surgery
J CATARACT REFRACT SURG - VOL 31, SEPTEMBER 25 Pharmacological management of night vision disturbances after refractive surgery Results of a randomized clinical trial Alessandro Randazzo, MD, Francesco
Age-Related Eye Diseases and Conditions. See Well for a Lifetime
Age-Related Eye Diseases and Conditions See Well for a Lifetime Vision Changes You may notice vision changes with aging. Many changes are common and can often be corrected. As you get older, you are at
Visual Field Analyzers from Carl Zeiss. Expanding your field of vision
Visual Field Analyzers from Carl Zeiss Expanding your field of vision Vision in focus Visual Field Analyzers Humphrey Field Analyzer/HFA II-i Series Humphrey Matrix Humphrey FDT Perimeter Software Guided
Regional workshop on the development of public health control strategies on glaucoma
Summary report on the Regional workshop on the development of public health control strategies on glaucoma Cairo, Egypt 14 16 December 2009 Summary report on the Regional workshop on the development of
Eye Manifestations of Lupus And Sjogren s Syndrome
Eye Manifestations of Lupus And Sjogren s Syndrome Based on a presentation by Dr. N. Kevin Wade at the BC Lupus Society Symposium held October 22, 2005. Background Dr. Wade completed his MD in 1998 at
The Nurse/Technician Role Within the Emerging Ophthalmic Technology - OCTs/B-Scan
The Nurse/Technician Role Within the Emerging Ophthalmic Technology - OCTs/B-Scan Margie V. Wilson, COMT Chief Clinical Supervisor UCSD Shiley Eye Center Thanks, Carol! Unfortunately. I have not financial
Miami VA Medical Center Residency in Primary Care with emphasis in Ocular Disease
Miami VA Medical Center Residency in Primary Care with emphasis in Ocular Disease Program Coordinator: Kasey Zann, O.D., F.A.A.O. 1201 NW 16th St Miami, FL 33125 [email protected] Mission: The mission
Cataracts. Cataract and Primary Eye Care Service...215-928-3041. Main Number...215-928-3000. Physician Referral...1-877-AT-WILLS 1-877-289-4557
Main Number...215-928-3000 Physician Referral...1-877-AT-WILLS 1-877-289-4557 Emergency Service...215-503-8080 Cataract and Primary Eye Care Service...215-928-3041 Retina Service... 215-928-3300 Cataract
Graduate Diploma in Optometry. Related modules Pre-requisites Satisfying requirements of second year BSc (Hons) Optometry examination board
Posterior Eye & General Ophthalmology School and subject group Module code Module title Module type Module replaces (where appropriate) Life and Health Sciences / Optometry OP3PEG Posterior Eye & General
2013 Diabetes and Eye Disease Fact Sheet
The Georgia Department of Public Health 2013 Diabetes and Eye Disease Fact Sheet Diabetes is the leading cause of new cases of blindness among United States adults. 1-3 As Georgia s population ages and
Thyroid Eye Disease. A Patient s Guide
Sashank Prasad, MD www.brighamandwomens.org/neuro-ophthalmology A Patient s Guide Symptoms Diagnosis Treatment Prognosis What are the symptoms of Thyroid Eye Disease? Patients with Thyroid Eye Disease
Optic Neuritis. The optic nerve fibers are coated with myelin to help them conduct the electrical signals back to your brain.
Optic Neuritis Your doctor thinks that you have had an episode of optic neuritis. This is the most common cause of sudden visual loss in a young patient. It is often associated with discomfort in or around
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014 The chart below lists the measures (and specialty exclusions) that eligible providers must
MODERN CLINICAL OPTOMETRY BILLING & CODING THE MEDICAL EYE EXAMINATION. Definitions of Eye Examinations. Federal Government Definition
MODERN CLINICAL OPTOMETRY BILLING & CODING THE MEDICAL EYE EXAMINATION Craig Thomas, O.D. 3900 West Wheatland Road Dallas, Texas 75237 972-780-7199 [email protected] Definitions of Eye Examinations Optometry
Help maintain homeostasis by capturing stimuli from the external environment and relaying them to the brain for processing.
The Sense Organs... (page 409) Help maintain homeostasis by capturing stimuli from the external environment and relaying them to the brain for processing. Ex. Eye structure - protected by bony ridges and
Thyroid Eye Disease. Anatomy: There are 6 muscles that move your eye.
Thyroid Eye Disease Your doctor thinks you have thyroid orbitopathy. This is an autoimmune condition where your body's immune system is producing factors that stimulate enlargement of the muscles that
The Big Data mining to improve medical diagnostics quality
The Big Data mining to improve medical diagnostics quality Ilyasova N.Yu., Kupriyanov A.V. Samara State Aerospace University, Image Processing Systems Institute, Russian Academy of Sciences Abstract. The
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015 The chart below lists the measures (and specialty exclusions) that eligible providers must
THE EYES IN MARFAN SYNDROME
THE EYES IN MARFAN SYNDROME Marfan syndrome and some related disorders can affect the eyes in many ways, causing dislocated lenses and other eye problems that can affect your sight. Except for dislocated
Welcome to our Office!
Randy Burks, MD, FACS Raymond Gailitis, MD, FACS Northwest Medical Plaza 5800 Colonial Drive, Suite 100-103 Margate, Florida 33063 954-977-8770 Comprehensive Eye Care 954-969-0090 LASIK 954-977-8774 Fax
NEW HOPE AND CURE FOR GLAUCOMA TREATMENT Although the tools for glaucoma care have become more sophisticated and advanced over the past two decades,
NEW HOPE AND CURE FOR GLAUCOMA TREATMENT Although the tools for glaucoma care have become more sophisticated and advanced over the past two decades, the goal of cure is still beyond our reach, despite
Your one stop vision centre Our ophthalmic centre offers comprehensive eye management, which includes medical,
sight see OLYMPIA EYE & LASER CENTRE Your one stop vision centre Our ophthalmic centre offers comprehensive eye management, which includes medical, At the Olympia Eye & Laser Centre, our vision is to improve
Affiliation : ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY (ARVO). AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO)
Curriculum Vitae Federico Ricci, MD Name: Federico Ricci, MD. Titolo Accademico /Title: Professore Aggregato di Oftalmologia / Aggregate Professor of Ophthalmology Direttore UOSD Patologie Retiniche [Centro
Vitreo-Retinal and Macular Degeneration Frequently Asked Questions
Vitreo-Retinal and Macular Degeneration Frequently Asked Questions What is a Vitreo-Retinal specialist? Retinal specialists are eye physicians and surgeons who focus on diseases in the back of the eye
PATIENT INFORMATION FORM. Name: Address: City: State: Zip: Social Security Number: Telephone Numbers Home: Age: Sex: M / F Work: Email: Cell:
PATIENT INFORMATION FORM Name: Address: City: State: Zip: Social Security Number: Telephone Numbers DOB: Home: Age: Sex: M / F Work: Email: Cell: Marital Status: Single Married Spouse s Name: Widowed Divorced
Avastin (Bevacizumab) Intravitreal Injection
Avastin (Bevacizumab) Intravitreal Injection This handout describes how Avastin may be used to treat wet age related macular degeneration (AMD) or macular edema due to retinal vascular disease such as
Ophthalmic Innovation 2015 A View from the AAO
Ophthalmic Innovation 215 A View from the AAO Ophthalmic Innovation 215: a view from the AAO IRIS David W. Parke II, MD CEO American Academy of Ophthalmology Introduction to AAO s IRIS Registry IRIS Registry
Psychiatrists and Reporting on Meaningful Use Stage 1. August 6, 2012
Psychiatrists and Reporting on Meaningful Use Stage 1 August 6, 2012 Quick Overview Functional Measures Providers (tracked by NPI) must report on 15 core objectives and associated measures and 5 objectives
Year Qualification Academic Institute Country 1980-1986 Degree in Medicine La Sapienza Italy University, Rome 1987 State professional
Curriculum Vitae 3 Edited with the trial version of Foxit Advanced PDF Editor To remove this notice, visit: www.foxitsoftware.com/shopping PERSONAL INFORMATION ALFONSO ANANIA Year of Birth: 1961 nationality
CATARACT AND LASER CENTER, LLC
CATARACT AND LASER CENTER, LLC Patient Information Date: Patient Name: M F Address: Street City State Zip Home Phone: Work Phone: Cell Phone: E-Mail : Referred by: Medical Doctor: Who is your regular eye
WELCOME TO COPPELL VISION CENTER
WELCOME TO COPPELL VISION CENTER Please Print Name Address Sex: Male Female City/State/Zip Age Home Phone of Birth Alternate Phone SSN# Profession Employed By Responsible Party Address and Phone Number
LOCSU Enhanced Services
LOCSU Enhanced Services Glaucoma Repeat Readings & OHT Monitoring Enhanced Service Pathway Issued by Local Optical Committee Support Unit May 2009 [Revised June 2012] Contents Page Executive Summary...
Scanning laser polarimetry and retinal thickness analysis before and after laser in situ k e r a t o m i l e u s i s
European Journal of Ophthalmology / Vol. 15 no. 4, 2005 / pp. 434-440 Scanning laser polarimetry and retinal thickness analysis before and after laser in situ k e r a t o m i l e u s i s E.M. HOFFMANN,
Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU
FOR MS RELAPSES Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU As a person with multiple sclerosis (MS), you know firsthand the profound impact MS relapses can have on your
DISTANCE LEARNING COURSE. Anatomy of the Patient Exam. 2008 2012, BSM Consulting All rights reserved.
DISTANCE LEARNING COURSE Anatomy of the Patient Exam 2008 2012, BSM Consulting All rights reserved. Table of Contents OVERVIEW... 1 PRELIMINARY WORK-UP... 1 OTHER DIAGNOSTIC TESTING... 3 DIAGNOSIS... 4
iocutouchtm for ipad Contents of Videos and Still Images Anatomy 906. Normal Eye and Orbit - no labels 907. Normal Eye and Orbit - with labels
iocutouchtm for ipad Contents of Videos and Still Images Anatomy 906. Normal Eye and Orbit - no labels 907. Normal Eye and Orbit - with labels Normal Eye 474. Normal Eye overview 476. Cornea - overview
~Contributing to Eye Health~
~Contributing to Eye Health~ 26 Eye Care Market Trends FY2007 Retinal Camera market forecasts by eye disease FY 2010 Auto Keratorefractometer Retina 160 Refraction Retina 200 Refraction Auto Lens Edger
The pinnacle of refractive performance.
Introducing! The pinnacle of refractive performance. REFRACTIVE SURGERY sets a new standard in LASIK outcomes More than 98% of patients would choose it again. 1 It even outperformed glasses and contacts
